{
}
Coherent Market Insights offers comprehensive reports on the Artificial Intelligence in Healthcare market, detailing market size, growth rates, and key players like GE Healthcare and Siemens Healthineers. The analysis covers various regions, providing insights into trends, challenges, and opportunities for stakeholders through 2031. The report emphasizes actionable insights and reliable data to support strategic decision-making in the post-COVID-19 landscape.
UBS has reduced its price target for LVMH from 660 to 629 euros, maintaining a "Neutral" rating following disappointing third-quarter sales figures. Analyst Zuzanna Pusz noted that the weaker-than-expected performance is likely to dampen investor sentiment, with declining demand for luxury goods observed not only in China but globally.
UBS has lowered its price target for L'Oreal, as reported by Cercle Finance. BOURSORAMA, acting solely as a distribution channel, emphasizes that the analysis is provided "as is" without any warranties, and the opinions expressed do not reflect its views. The institution maintains a conflict of interest management policy to ensure objectivity in its investment recommendations.
LVMH Moët Hennessy Louis Vuitton SE, the global leader in luxury goods, generates sales primarily from fashion and leather goods (48.9%), followed by watches and jewelry (12.7%), perfumes and cosmetics (9.6%), and wines and spirits (7.7%). The company operates 6,097 stores worldwide, with significant sales contributions from Asia (30.8%) and the United States (25.3%).
UBS has lowered its price target for LVMH to €629 from €660, maintaining a Neutral rating after disappointing Q3 2024 sales figures. The group's organic sales growth fell by 3%, significantly underperforming consensus estimates, leading to a reduction in EPS forecasts for 2024-2026 by 3-4%. Total Q3 sales reached €19,076 million, 5% below consensus expectations.
UBS has lowered its price target for LVMH, as reported by Cercle Finance. BOURSORAMA, acting solely as a distribution channel, emphasizes that it has not influenced the analysis and holds no responsibility for its content. The institution maintains a conflict of interest management policy to ensure objectivity in its investment recommendations.
UBS has lowered its price target for LVMH to €629 from €660, maintaining a Neutral rating after disappointing Q3 2024 sales figures. The group's organic sales growth fell by 3%, significantly underperforming consensus estimates, leading to a reduction in EPS forecasts for 2024-2026. Total Q3 sales reached €19,076 million, 5% below consensus expectations.
The French Senate has raised concerns over the financialization of healthcare, noting its impact on the organization of care and the independence of professionals. A report highlights that private investment has surged, particularly in the hospital and medical biology sectors, with four groups dominating 40% of the private hospital market. Despite regulations intended to limit financial ownership in medical biology laboratories, investment funds now control two-thirds of the sector, reflecting a growing trend in dental and ophthalmological centers as well.
Global M&A activity saw a 10% increase in deal value in the first nine months of 2024, reaching $1.6 trillion, despite mixed results across regions. While North America and Europe showed signs of recovery, the Asia-Pacific region hit a ten-year low, primarily due to declines in China. Stricter regulatory scrutiny has delayed over 40% of transactions, complicating the deal-making landscape.
UBS has lowered its target for L'Oréal to 415 euros, maintaining a 'Neutral' rating. As the world's leading cosmetics group, L'Oréal's sales are primarily driven by skin care (39.9%), make-up (19.7%), and hair care products (15.4%), with significant contributions from luxury and active cosmetics. Geographically, net sales are distributed across Europe (31.6%), North America (27%), and North Asia (25.9%), among others.
FRA
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
actionable insights on artificial intelligence in healthcare market trends and forecasts
Euro
United States Dollar
Biosymetrics
Canon Medical Systems
NVIDIA Corporation
Intel Corporation
Microsoft Corporation
Arterys
Exscientia
Viz.ai Inc.
Oncora Medical
Babylon Health
Siemens Healthineers AG
PathAI
Philips Healthcare
Google Health
Aidoc Medical Ltd.
Ada Health GmbH
Komodo Health
GE HealthCare Technologies Inc.
Butterfly Network, Inc.
Relay Therapeutics, Inc.
RUS
DEU
ARG
USA
CAN
JPN
IND
ISR
ARE
MEX
GBR
FRA
ZAF
KOR
BRA
SAU
CHN
ITA
Vaagisha Shah
Show more
13:06 16.10.2024
UBS lowers LVMH price target amid weaker luxury goods demand
13:04 16.10.2024
ubs lowers price target for l'oreal in recent analysis
10:36 16.10.2024
LVMH sales breakdown highlights luxury goods dominance across global markets
10:20 16.10.2024
ubs lowers lvmh price target after disappointing q3 sales results
10:20 16.10.2024
ubs lowers price target for lvmh in recent analysis
10:15 16.10.2024
ubs lowers lvmh price target after disappointing q3 sales results
10:15 16.10.2024
financial sector increasingly influences healthcare system in france
Euro
Biogroup-LCD
Amalviva
Ramsay Sante
Synlab Adour
EUROFINS ABFH
Inovie CBM
Unilabs 4
Vivalto SAS
Cerballiance Artois
Elsan Direct SAS
FRA
Corinne Imbert
Olivier Henno
Bernard Jomier
Show more
10:02 16.10.2024
global mergers and acquisitions show mixed recovery amid regulatory challenges
Australian Dollar
Japanese Yen
United States Dollar
Chinese Yuan
Euro
Boston Consulting Group AG (Switzerland)
DEU
USA
AUT
JPN
CZE
CHE
IND
SWE
GBR
FRA
AUS
MYS
KOR
SGP
CHN
ITA
Jens Kengelbach
Daniel Friedman
Show more
09:17 16.10.2024
ubs lowers l'oreal target price to 415 euros maintaining neutral rating
Euro
Yves Saint Laurent Beauté
Giorgio Armani Beauty
Prada S.p.A.
L'Oréal S.A.
Ralph Lauren Corporation
TWN
ITA
BRA
FRA
JPN
HKG
USA
KOR
CHN
AUS
Show more
23:17 15.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Finance Mergers & Acquisitions
Global Financial Events
CEO Changes
Retail and Consumer Goods
Banking Regulations
Market Analysis and Predictions
Industry Mergers & Acquisitions
Global Trade Developments
Energy Sector Developments
Startups & Entrepreneurship
Government Policies
Supply Chain Management
Domestic Politics
Financial Scams and Security
Government Economic Policies
Central Bank Actions
Hedge Funds & Private Equity
Countries:
Companies:
Tesla, Inc.
Barclays PLC
JPMorgan Chase & Co.
Apple Inc.
BNP Paribas SA
UBS Group AG
NVIDIA Corporation
Morgan Stanley
Bank of America Corporation
Capital One Financial Corporation
The Goldman Sachs Group, Inc.
Deutsche Bank RV Global PP
Amazon.com, Inc.
Citigroup Inc.
Commerzbank AG
SpaceXCoin USD
Credit Suisse Real Estate Fund Siat
Wells Fargo & Company
UniCredit S.p.A.
Microsoft Corporation
Currencies:
United States Dollar
Euro
Chinese Yuan
Indian Rupee
Swiss Franc
British Pound Sterling
Vietnamese Đồng
Hong Kong Dollar
Australian Dollar
United Arab Emirates Dirham
Singapore Dollar
South Korean Won
Thai Baht
Norwegian Krone
Danish Krone
Swedish Krona
Russian Ruble
Ghanaian Cedi
Canadian Dollar
Turkish Lira
People: